brian slomovitz, md, offers opinion on the repeat use of parp inhibitors
Published 3 years ago • 27 plays • Length 0:39Download video MP4
Download video MP3
Similar videos
-
2:07
brian slomovitz, md, regarding the long term follow-up data on parp inhibitors in ovarian cancer
-
1:38
brian slomovitz, md, on incorporating biomarker-driven therapy in ovarian cancer
-
1:27
brian slomovitz, md, elaborates on the role of immunotherapy in ovarian cancer
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
1:02
where can parp inhibitors be used
-
4:57:06
be a part of the revolution - one-cell diagnostics
-
1:24:01
here's why you were asymptomatic and news roundup oct 19, 2022
-
54:40
parp inhibitors in 2020: where are we now, and where are we going | webinar | ambry genetics
-
7:25
the evolution of single-agent parp inhibitors
-
55:30
improving interprofessional management and clinical outcomes with parp inhibitors for advanced ov...
-
15:43
clinical data with parp inhibitors in ovarian cancer
-
23:32
role of parp inhibitor in ovarian cancer dr. thomas herzog
-
3:34
future of parp inhibitors in mcrpc
-
34:36
parp inhibitors with johnathan lederman
-
1:00:06
webinar: parp inhibitors and ovarian cancer
-
4:14
parp inhibition in ovarian cancer: what’s next?
-
0:58
data on parp inhibitor treatment in ovarian cancer presented at esmo
-
3:53
mbcc 2017: multiple parp inhibitors show promise in breast cancer treatment
-
8:55
ovarian cancer: selecting between available parps
-
2:22
clinical trials investigating parp inhibitors in prostate cancer
-
2:36
sabcs: parp inhibitor data called 'spectacular'
-
5:20
add-on parp inhibition in metastatic crpc: propel and magnitude | david vanderweele